Covered recipient · General Payments record
MICHAEL JONATHAN SLESINSKI
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation
General Payments · PY2018–2024
$2,721.33
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $602.25 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $195.34 | 9 |
| Nalu Medical, Inc. | $150.11 | 2 |
| TerSera Therapeutics LLC | $86.22 | 3 |
| Ipsen Biopharmaceuticals, Inc | $43.75 | 2 |
| Nevro Corp. | $33.21 | 1 |
| Collegium Pharmaceutical, Inc. | $20.39 | 1 |
| Abbott Laboratories | $19.64 | 1 |
| Avanos Medical | $19.20 | 1 |
| Averitas Pharma Inc. | $18.96 | 1 |
| BIOTISSUE HOLDINGS INC. | $15.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020212023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.64 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124845494 | CMS |
| ABBVIE INC. | $31.26 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106119043 | CMS |
| ABBVIE INC. | $34.51 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106119045 | CMS |
| ABBVIE INC. | $20.86 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106119047 | CMS |
| ABBVIE INC. | $21.94 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106119049 | CMS |
| ABBVIE INC. | $17.38 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106119051 | CMS |
| ABBVIE INC. | $16.90 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106119053 | CMS |
| ABBVIE INC. | $11.55 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106119055 | CMS |
| ABBVIE INC. | $15.83 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106119057 | CMS |
| ABBVIE INC. | $25.11 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106119059 | CMS |
| Avanos Medical | $19.20 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149308867 | CMS |
| Averitas Pharma Inc. | $18.96 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133446797 | CMS |
| BIOTISSUE HOLDINGS INC. | $15.43 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148751550 | CMS |
| Collegium Pharmaceutical, Inc. | $20.39 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135289682 | CMS |
| Ipsen Biopharmaceuticals, Inc | $22.92 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091990981 | CMS |
| Ipsen Biopharmaceuticals, Inc | $20.83 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091990983 | CMS |
| Nalu Medical, Inc. | $21.69 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133995867 | CMS |
| Nalu Medical, Inc. | $128.42 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133995869 | CMS |
| Nevro Corp. | $33.21 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130764837 | CMS |
| TerSera Therapeutics LLC | $25.63 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144717093 | CMS |
| TerSera Therapeutics LLC | $30.98 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144717095 | CMS |
| TerSera Therapeutics LLC | $29.61 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144717097 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.